MA27760A1 - Enduit a ongles antifongique et procede d'utilisation - Google Patents

Enduit a ongles antifongique et procede d'utilisation

Info

Publication number
MA27760A1
MA27760A1 MA28543A MA28543A MA27760A1 MA 27760 A1 MA27760 A1 MA 27760A1 MA 28543 A MA28543 A MA 28543A MA 28543 A MA28543 A MA 28543A MA 27760 A1 MA27760 A1 MA 27760A1
Authority
MA
Morocco
Prior art keywords
fungicidal
composition
coat
amount
antifungal
Prior art date
Application number
MA28543A
Other languages
English (en)
Inventor
Stanley W Kepka
Y Joseph Mo
Hang-Yong Wang
Mingqi Lu
William R Pfister
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of MA27760A1 publication Critical patent/MA27760A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne une composition d'enduit à ongles antifongique à double effet et un procédé d'utilisation afin d'améliorer ou d'empêcher une infection fongique des ongles et en particulier onychomycose. L'invention concerne en outre des compositions de type monocouche et double couche convenables pour des applications quotidiennes fongicides. Une composition d'enduit à ongles antifongique préférée contient une quantité efficace de fongicide, une quantité d'un promoteur de perméation sensiblement non volatil, une quantité d'un polymère hydrophile, formant une couche, et un support volatile pharmaceutiquement acceptable. Cette composition fournit un enduit fongicide sensiblement soluble dans l'eau après mise en contact avec une ongle susceptible d'infections fongiques ou ayant une infection fongique.
MA28543A 2003-03-21 2005-10-11 Enduit a ongles antifongique et procede d'utilisation MA27760A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45668403P 2003-03-21 2003-03-21

Publications (1)

Publication Number Publication Date
MA27760A1 true MA27760A1 (fr) 2006-02-01

Family

ID=33098141

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28543A MA27760A1 (fr) 2003-03-21 2005-10-11 Enduit a ongles antifongique et procede d'utilisation

Country Status (28)

Country Link
US (3) US7462362B2 (fr)
EP (2) EP1635770B1 (fr)
JP (1) JP4540667B2 (fr)
KR (1) KR101093990B1 (fr)
CN (2) CN102973420A (fr)
AT (2) ATE512672T1 (fr)
AU (1) AU2004224326B2 (fr)
BR (1) BRPI0408613A (fr)
CA (1) CA2519705C (fr)
CO (1) CO5640092A2 (fr)
CY (1) CY1111773T1 (fr)
DE (1) DE602004021253D1 (fr)
DK (2) DK2106805T3 (fr)
EC (1) ECSP056110A (fr)
ES (1) ES2366273T3 (fr)
HR (1) HRP20050918A2 (fr)
IL (1) IL170963A (fr)
IS (1) IS8078A (fr)
MA (1) MA27760A1 (fr)
MX (1) MXPA05010114A (fr)
NO (1) NO335895B1 (fr)
NZ (1) NZ542904A (fr)
PL (1) PL2106805T3 (fr)
RU (1) RU2358718C2 (fr)
SG (1) SG152065A1 (fr)
TN (1) TNSN05231A1 (fr)
WO (1) WO2004084826A2 (fr)
ZA (1) ZA200507972B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
CA2590136A1 (fr) * 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions et methodes destinees a traiter des affections de l'ongle
EP1698336A1 (fr) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Compositions antifongiques comprenant le sertaconazole ainsi que l' hydrocortisone ou un agent antibactérien
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
WO2007076619A1 (fr) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Préparations pharmaceutiques pour le traitement de maladies des ongles
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
MX2008011433A (es) * 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
EP2005959B1 (fr) 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Composition pharmaceutique pour l'usage externe
JP5160409B2 (ja) 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
WO2009031643A1 (fr) 2007-09-05 2009-03-12 Pola Pharma Inc. Composition antifongique
PL2191828T3 (pl) 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2010039251A1 (fr) * 2008-10-03 2010-04-08 Nexmed Holdings, Inc. Composition stabilisée pour traiter le psoriasis
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
WO2010047288A1 (fr) 2008-10-24 2010-04-29 Semiconductor Energy Laboratory Co., Ltd. Procédé de fabrication d’un dispositif semi-conducteur
JP2012511027A (ja) * 2008-12-04 2012-05-17 チョンシー ユー 高透過性組成物およびその用途
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
WO2010086732A1 (fr) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions stables destinées au traitement des ongles et de la peau
WO2010086725A1 (fr) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions pour le traitement des ongles et de la peau
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117091A2 (fr) 2009-04-09 2010-10-14 Pola Pharma Inc. Composition pharmaceutique antimycotique
WO2011014850A2 (fr) 2009-07-31 2011-02-03 Nuvo Research Inc. Formulations à usage topique à base d'un eutectique
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
EP2522336A4 (fr) * 2009-11-02 2014-08-27 Fukumotogiken Corp Co Ltd Composition cosmétique pour la peau malaxée et son procédé de production, et méthode d'utilisation de la composition cosmétique pour la peau malaxée
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
EP2566325A4 (fr) 2010-05-04 2014-06-11 Nexmed Holdings Inc Compositions d'agents thérapeuthiques à petites molécules
SG10201600228QA (en) * 2010-05-04 2016-03-30 Nexmed Holdings Inc Therapeutic peptide composition and method
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
RU2432158C1 (ru) * 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
NZ609826A (en) * 2010-12-02 2016-03-31 Nexmed Holdings Inc Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
AU2012241018B2 (en) * 2011-04-08 2015-11-12 Pfizer Inc. Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
CA2835684C (fr) * 2011-05-11 2019-10-08 Alc Therapeutics, Llc Compositions antifongiques pour le traitement de la peau et des ongles
CA2745320A1 (fr) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Dispositif de reconstitution
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
JP6122035B2 (ja) * 2012-02-17 2017-04-26 ヴェローチェ・バイオファーマ・エルエルシー 皮膚および爪の治療のための抗真菌組成物
CA2775393C (fr) * 2012-05-02 2014-04-29 Samy Saad Formulations pharmaceutiques topiques non aqueuses
AR091934A1 (es) 2012-07-30 2015-03-11 Meiji Seika Pharma Co Ltd Parche para antidermatofitosis
AR092358A1 (es) * 2012-07-30 2015-04-15 Meiji Seika Pharma Co Ltd Agente liquido topico para el tratamiento de la dermatofitosis
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CA2904703A1 (fr) 2013-03-14 2014-10-02 Hallux, Inc. Procede de traitement d'infections, maladies ou troubles d'unite d'ongle
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
SG11201602596UA (en) 2013-10-03 2016-04-28 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions
EP3071295A4 (fr) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Procédés, compositions et dispositifs anti-infectieux
EP2952208A1 (fr) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Système hydroalcoolique de traitement des ongles
US10562858B2 (en) 2014-08-13 2020-02-18 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton agents and preparation process thereof
CA2973725A1 (fr) 2015-01-20 2016-07-28 Veloce Biopharma Llc Nouvelle composition iodophore et procedes d'utilisation
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069633D1 (en) 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
US4406509A (en) * 1981-11-25 1983-09-27 E. I. Du Pont De Nemours & Co. Jack and plug electrical assembly
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
EP0746294B1 (fr) * 1993-10-07 2004-12-22 Odontex, Inc. Composes pour ameliorer l'absorption topique de formulations pharmaceutiques
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6118020A (en) 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6495124B1 (en) 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
WO2001060325A1 (fr) * 2000-02-16 2001-08-23 Bentley Pharmaceuticals, Inc. Composition pharmaceutique
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
AU2000255769A1 (en) * 2000-07-01 2002-01-14 Chemtech Research Incorporation Process for preparation of terbinafine and its hydrochloride as an antifungal agent
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
JP2006520800A (ja) 2006-09-14
ZA200507972B (en) 2007-02-28
CN102973420A (zh) 2013-03-20
JP4540667B2 (ja) 2010-09-08
CY1111773T1 (el) 2015-10-07
PL2106805T3 (pl) 2011-10-31
KR101093990B1 (ko) 2011-12-16
EP1635770A2 (fr) 2006-03-22
DE602004021253D1 (de) 2009-07-09
BRPI0408613A (pt) 2006-03-07
TNSN05231A1 (fr) 2007-06-11
AU2004224326A1 (en) 2004-10-07
WO2004084826A3 (fr) 2004-11-04
MXPA05010114A (es) 2006-04-27
EP2106805A1 (fr) 2009-10-07
CO5640092A2 (es) 2006-05-31
NZ542904A (en) 2009-04-30
ATE512672T1 (de) 2011-07-15
CA2519705A1 (fr) 2004-10-07
ECSP056110A (es) 2006-03-01
US7462362B2 (en) 2008-12-09
CA2519705C (fr) 2013-07-02
SG152065A1 (en) 2009-05-29
RU2005132390A (ru) 2006-06-27
NO20054830D0 (no) 2005-10-19
EP2106805B1 (fr) 2011-06-15
CN1791378A (zh) 2006-06-21
HRP20050918A2 (en) 2006-12-31
RU2358718C2 (ru) 2009-06-20
NO335895B1 (no) 2015-03-16
EP1635770A4 (fr) 2007-12-26
US20090099266A1 (en) 2009-04-16
ES2366273T3 (es) 2011-10-18
US20060067898A1 (en) 2006-03-30
WO2004084826A2 (fr) 2004-10-07
ATE432087T1 (de) 2009-06-15
EP1635770B1 (fr) 2009-05-27
DK2106805T3 (da) 2011-08-15
NO20054830L (no) 2005-12-16
IS8078A (is) 2005-10-18
DK1635770T3 (da) 2009-08-03
IL170963A (en) 2010-12-30
US20130323189A1 (en) 2013-12-05
KR20060003868A (ko) 2006-01-11
AU2004224326B2 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
TNSN05231A1 (fr) Enduit a ongles antifongique et procede d'utilisation
ATE238751T1 (de) Antimykotischer nagellack
WO2002074276A3 (fr) Compositions et kits pour soins dentaires
WO2002074274A3 (fr) Kits et compositions pour soins bucco-dentaires
DE60000103D1 (de) Eine wässrige polymerdispersion enthaltender nagellack
EP1059308A4 (fr) Polymere et composition solidifiable
AU2003285389A1 (en) Nail varnish composition comprising a sequenced polymer
CY1106459T1 (el) Τσιροτο το οποιο περιλαμβανει σερτακοναζολη για την θεραπεια δυσλειτουργιων και διαταραχων των νυχιων
MXPA05004962A (es) Pelicula laminada de barrera de gas.
DE60326966D1 (de) Selbstvernetzbare wässrige beschichtungszusammensetzung
ATE556698T1 (de) Kosmetische zusammensetzung mit einem flockenden wasserlöslichen polymer als antiperspirans; verfahren zur behandlung von perspiration
WO2007094999A3 (fr) Compositions antifongiques pour les ongles
WO2003011923A8 (fr) Copolymeres destines a des compositions de revetement
EP1152014A4 (fr) Composition de resine
DK1170342T3 (da) Oplösningsmiddelholdige UV-strålehærdende belægningsstoffer
WO2004048421A3 (fr) Copolymeres cationiques ramifies et procedes d'utilisation antimicrobienne
TH45854A3 (th) สารผสมเคลือบเล็บโพลิอะคริลและโพลิยูรีเทน
BR0016140A (pt) Composição de reticulação, composição curável, composição de emulsão curável, e, método de revestimento de um substrato
ATE283321T1 (de) Zweischichtlackierung aus wässrigem basislack und klarlack mit verbesserter klarlackbenetzungsgrenze
US20050123491A1 (en) Composition and method for treating onychomycosis
HUP9800933A2 (en) Desinfecting and regenerative nail polish remover
TH47666A3 (th) ผลิตภัณฑ์เคลือบเล็บที่ทนทาน ซึ่งมีสมบัติของพื้นผิวที่นิยามไว้